NEW YORK, April 21, 2015 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Moments ago, Analysts Review released new research updates concerning several important developing situations including MediciNova Inc. (NASDAQ: MNOV), Cardica Inc. (NASDAQ: CRDC), Rosetta Genomics Inc. (NASDAQ: ROSG), Gulf Port Energy Corp (NASDAQ: GPOR), and Matador Resources Co. (NYSE: MTDR). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
To access our full PDF reports on a complementary basis, please visit the links below.
Today's update concerns the following companies:
Full PDF Download Links (you may have to copy and paste the following links into your browser):
MNOV Research Report: ( http://get.analystsreview.com/pdf/?c=MediciNova%20Inc.&d=21-Apr-2015&s=MNOV ),
CRDC Research Report: ( http://get.analystsreview.com/pdf/?c=Cardica%20Inc.&d=21-Apr-2015&s=CRDC ),
ROSG Research Report: ( http://get.analystsreview.com/pdf/?c=Rosetta%20Genomics%20Inc.&d=21-Apr-2015&s=ROSG ),
GPOR Research Report: ( http://get.analystsreview.com/pdf/?c=Gulf%20Port%20Energy&d=21-Apr-2015&s=GPOR ),
MTDR Research Report: ( http://get.analystsreview.com/pdf/?c=Matador%20Resources&d=21-Apr-2015&s=MTDR ).
Analyst Update: Public Offering, Results, Approvals, and Public Offerings
Reviewed by: Rohit Tuli, CFA®
U.S. stocks rallied on Monday, triggered by some good first-quarter earnings reports. The NASDAQ gained 1.27% or 62.79 points, to finish at 4,994.60; the Dow Jones Industrial Average advanced 1.17%, or 208.63 points to 18,034.93, and the S&P 500 ended the session at 2,100.40, up 0.92% or 19.22 points. The gains were broad based as all the sectors closed the session in positive. European stocks too edged higher on Monday, as aggressive easing policy in China offsets the impact of Greece turmoil. Major European markets ended the session higher, as Germany's DAX rose 1.74%; France's CAC advanced 0.86%, and Britain's FTSE 100 jumped 0.82%. Meanwhile, Asian markets mostly disappointed on Monday, amid rising concern over slowdown in the Chinese economy. The Shanghai Composite and Japan's Nikkei both closed lower.
On April 16, 2015, shares of MediciNova Inc. shot up by a whopping 41.31% to close the day at $4.96. The Company had announced on the same day that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for MN-001 (tipelukast) for the treatment of patients with nonalcoholic steatohepatitis (NASH) with fibrosis.
On February 5, 2015, Cardica Inc. came out with its fiscal 2015 second quarter and six months results for the period ended December 31, 2015. Total product sales were approximately $0.6 million for the quarter, compared to $0.8 million for the fiscal 2014 second quarter. Total net revenue was approximately $0.7 million for the second quarter, compared to $0.9 million for Q2 FY 2014.
On April 16, 2015, the stocks of Rosetta Genomics Inc. were trading up by 2.16% and ended the day at $3.78. The Company announced on the same day the receipt of a Notice of Allowance for U.S. Patent Application No. 13/856,190, entitled, "Methods and materials for classification of tissue of origin of tumor samples."
On April 16, 2015, Gulfport Energy announced that it has priced at par an offering of $350 million aggregate principal amount of its 6.625% Senior Notes due 2023. This represents a $50 million increase in the size of the offering from $300 million principal amount announced at the launch on April 15, 2015.
On April 16, 2015, Matador Resources announced that it has priced an underwritten public offering of 7,000,000 shares of its common stock. Total estimated proceeds of the offering to Matador, before estimated offering expenses, are approximately $189 million. The offering is expected to close on April 21, 2015, subject to customary closing conditions.
About Analysts Review
At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.
Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.
Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review